Access Clinical Trials - Nashville

Nashville, Tennessee 37203

0 studies enrolling now · 1 studies all time

What they study most

Chronic Migraine

Studies at this site

• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling